Chicago, IL, United States of America

Alan C Tsurutani

This inventor holds 2 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1997-1998.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alan C Tsurutani: Innovator in Drug Stability

Introduction

Alan C Tsurutani is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of drug stability, holding 2 patents that focus on enhancing the stability of important pharmaceutical compounds.

Latest Patents

His latest patents include "Stabilized standards and calibrators containing rapamycin" and "The present invention is directed to an in vitro aqueous composition comprising a drug, preferably tacrolimus or rapamycin, having enhanced stability." This invention utilizes a binding protein, preferably FKBP, to stabilize the drug in an aqueous matrix. Another patent, "Stabilized standards and calibrators containing rapamycin and tacrolimus," also focuses on an in vitro aqueous composition that enhances the stability of tacrolimus or rapamycin using antibodies as stabilizing agents.

Career Highlights

Alan C Tsurutani is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work has contributed to advancements in drug formulation and stability, which are crucial for effective medical treatments.

Collaborations

He has collaborated with notable coworkers such as Frank C Grenier and Thomas F Holzman, further enhancing the innovative efforts within his team.

Conclusion

Alan C Tsurutani's work in drug stability exemplifies the importance of innovation in the pharmaceutical industry. His patents reflect a commitment to improving the efficacy and reliability of critical medications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…